- Home
- CISS vs SHPH Comparison
CISS vs SHPH Comparison
Compare CISS & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- SHPH
- Stock Information
- Founded
- CISS 2022
- SHPH 2012
- Country
- CISS Greece
- SHPH United States
- Employees
- CISS N/A
- SHPH N/A
- Industry
- CISS Marine Transportation
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- CISS Consumer Discretionary
- SHPH Health Care
- Exchange
- CISS Nasdaq
- SHPH Nasdaq
- Market Cap
- CISS 11.9M
- SHPH 3.3M
- IPO Year
- CISS N/A
- SHPH 2022
- Fundamental
- Price
- CISS $1.16
- SHPH $1.29
- Analyst Decision
- CISS
- SHPH
- Analyst Count
- CISS 0
- SHPH 0
- Target Price
- CISS N/A
- SHPH N/A
- AVG Volume (30 Days)
- CISS 146.9K
- SHPH 42.2K
- Earning Date
- CISS 11-01-2024
- SHPH 11-12-2024
- Dividend Yield
- CISS N/A
- SHPH N/A
- EPS Growth
- CISS N/A
- SHPH N/A
- EPS
- CISS N/A
- SHPH N/A
- Revenue
- CISS $47,503,090.00
- SHPH N/A
- Revenue This Year
- CISS N/A
- SHPH N/A
- Revenue Next Year
- CISS N/A
- SHPH N/A
- P/E Ratio
- CISS N/A
- SHPH N/A
- Revenue Growth
- CISS 264.29
- SHPH N/A
- 52 Week Low
- CISS $1.08
- SHPH $1.03
- 52 Week High
- CISS $68.50
- SHPH $4.96
- Technical
- Relative Strength Index (RSI)
- CISS 49.27
- SHPH 46.55
- Support Level
- CISS $1.08
- SHPH $1.12
- Resistance Level
- CISS $1.25
- SHPH $1.26
- Average True Range (ATR)
- CISS 0.05
- SHPH 0.11
- MACD
- CISS 0.01
- SHPH 0.05
- Stochastic Oscillator
- CISS 47.06
- SHPH 59.09
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.